— Know what they know.
Not Investment Advice

300006.SZ SHZ

Chongqing Lummy Pharmaceutical Co., Ltd.
1W: +0.0% 1M: -2.6% 3M: +11.9% YTD: +8.2% 1Y: +9.0% 3Y: +62.1% 5Y: -23.0%
¥5.56 ($0.83)
+0.26 (+4.91%)
 
SHZ · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 60 · ¥5.9B mcap · 889M float · 4.04% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap¥5.9B ($875.3M)
52W Range4.1-6.86
Volume34,433,879
Avg Volume35,911,770
Beta0.43
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORongzhao Qiu
Employees973
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2009-10-30
Building B, Huangshan Avenue
Chongqing, CH 401121
CN
86 23 6730 0382
About Chongqing Lummy Pharmaceutical Co., Ltd.

Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the research, development, production, and distribution of a broad spectrum of pharmaceutical products. Its extensive portfolio encompasses treatments for various therapeutic areas, including oncology, infectious diseases (antibacterial, antiviral, and antifungal), liver support, and endocrine disorders. The company also develops and markets medications for the digestive, immune, blood, cardiovascular, and nervous systems, in addition to traditional Chinese patent medicines. Further offerings include electrolyte and acid-base balancing agents, nutritional supplements, large volume parenteral solutions, American ginseng preparations, and active pharmaceutical ingredients. Established in 1999, the company's headquarters are located in Chongqing, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms